Treatment Options for Dementia with Lewy Bodies: A Network Meta-Analysis of Randomised Control Trials
ConclusionDespite the lack of statistical significance, when assessing the efficacy and safety outcomes for each drug in the evidence network, donepezil appeared to have a more favourable overall benefit/risk profile for patients with DLB. Further comparative trials are required to improve understanding of the true difference between existing and potential future treatment options.
Source: Neurology and Therapy - Category: Neurology Source Type: research
More News: Alzheimer's | Brain | Dementia | Donepezil | Japan Health | Men | Namenda | Neurology | Parkinson's Disease | Psychiatry | Seroquel | Statistics | Study